Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer
Clinical trial NCT02158507 · COMPLETED
Trial details
- NCT number
- NCT02158507
- Sponsor
- University of Alabama at Birmingham
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-04
- Primary completion
- 2021-07-22
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.